Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysis by Wardlaw, Joanna M, Prof, Murray, Veronica, Prof, Berge, Eivind, Prof, del Zoppo, Gregory, Prof, Sandercock, Peter, Prof, Lindley, Richard L, Prof, Cohen, Geoff, PhD

Get full text

Effects of alteplase on survival after ischaemic stroke (IST-3): 3 year follow-up of a randomised, controlled, open-label trial by Berge, Eivind, Prof, Cohen, Geoffrey, MSc, Roaldsen, Melinda B, MD, Lundström, Erik, MD, Isaksson, Eva, BN, Rudberg, Ann-Sofie, MD, Slot, Karsten Bruins, MD, Forbes, John, Prof, Smith, Joel, PhD, Drever, Jonathan, BSc, Wardlaw, Joanna M, Prof, Lindley, Richard I, Prof, Sandercock, Peter A G, Prof, Whiteley, William N, MD

Get full text

The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial by Sandset, Else Charlotte, MD, Bath, Philip MW, Prof, Boysen, Gudrun, Prof, Jatuzis, Dalius, MD, Kõrv, Janika, MD, Lüders, Stephan, MD, Murray, Gordon D, Prof, Richter, Przemyslaw S, MD, Roine, Risto O, Prof, Terént, Andreas, Prof, Thijs, Vincent, MD, Berge, Eivind, Dr

Get full text

Increasing value and reducing waste in stroke research by Berge, Eivind, PhD, Salman, Rustam Al-Shahi, Prof, van der Worp, H Bart, PhD, Stapf, Christian, Prof, Sandercock, Peter, Prof, Sprigg, Nikola, DM, Macleod, Malcolm R, Prof, Kelly, Peter J, Prof, Nederkoorn, Paul J, MD, Ford, Gary A, MD

Get full text